Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder

NCT00150605 is registered in ClinicalTrials.gov with Validus Pharmaceuticals as lead sponsor.

NCT NCT00150605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder
Lead sponsor
Validus Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
October 31, 2005
Enrollment
50
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder